Previous Article | Next Article ![]()
Infection and Immunity, March 2001, p. 1298-1305, Vol. 69, No. 3
Laboratoire de Gastroenterologie et
Nutrition1 and INSERM U
364,2 IFR50, Faculté de
Médecine, Université de Nice-Sophia Antipolis, 06107 Nice Cedex 2, France
Received 5 July 2000/Returned for modification 5 October
2000/Accepted 29 November 2000
Enteropathogenic Escherichia coli (EPEC) infection of
T84 cells induces a decrease in transepithelial resistance, the
formation of attaching and effacing (A/E) lesions, and cytokine
production. The purpose of this study was to investigate the ability of
EPEC to activate mitogen-activated protein (MAP) kinases in T84 cells and to correlate these signaling pathways with EPEC-induced cell responses. T84 cells were infected with either the wild-type (WT) EPEC
strain E2348/69 or two mutants, intimin deletion strain CVD206 (
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1298-1305.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Implication of Mitogen-Activated Protein Kinases in
T84 Cell Responses to Enteropathogenic Escherichia
coli Infection
eaeA) and type III secretion apparatus mutant strain
CVD452 (
escN::aphA). Infection of
T84 cells with WT but not mutant EPEC strains induced tyrosine
phosphorylation of several proteins in T84 cells,
including the p46 and p52 Shc isoforms. Kinetics studies revealed that
ERK1/2, p38, and c-Jun N-terminal kinase (JNK) MAP kinases were
activated in cells infected with strain E2348/69 but not with the
mutant strains. Inhibition of MAP kinases with PD98059 or SB203580 did
not affect the EPEC-induced decrease in transepithelial resistance or
actin accumulation beneath the WT bacteria, but these two inhibitors
significantly decreased interleukin-8 (IL-8) synthesis. We
demonstrate that EPEC induces activation of ERK1/2, p38, and JNK
cascades, which all depend on bacterial adhesion and expression of the
bacterial type III secretion system. ERK1/2 and p38 MAP kinases were
equally implicated in IL-8 expression but did not participate in A/E
lesion formation or transepithelial resistance modification, indicating
that the signaling pathways involved in these events are distinct.
*
Corresponding author. Mailing address: Laboratoire de
Gastroenterologie, Université de Nice-Sophia Antipolis, 28 avenue
de Valombrose, 06107 Nice cedex 2, France. Phone: (33) 4 93 37 76 95. Fax: (33) 4 93 81 77 10. E-mail: czerucka{at}unice.fr.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|